-
Mashup Score: 178Treating Older Patients in Cardiogenic Shock with a Microaxial Flow Pump: Is it DANGERous?: - 18 day(s) ago
Read the full article here
Tweet
-
Mashup Score: 152Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation: - 18 day(s) ago
Read the full article here
Tweet
-
Mashup Score: 122
-
#AHA24: Hyperkalemia is a common side effect of using MRAs in #HFrEF. In #JACC, Drs. @MkosiborodMD, @markcpetrie20, and colleagues present results of the #REALIZEK trial evaluating the effects of sodium zirconium cyclosilicate to optimize spironolactone use in #heartfailure… https://t.co/dSAut7LLVU https://t.co/Q92EbPf7ac
Read the original tweet here
Tweet -
-
Mashup Score: 123Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of Four Trials: - 18 day(s) ago
Read the full article here
Tweet-
#AHA24: New in #JACC, Dr. @akshaydesaimd & team pool results on blood pressure from 4 #heartfailure trials: 🔹I-PRESERVE 🔹TOPCAT-Americas 🔹PARAGON-HF 🔹DELIVER They find both SBP & PP showed a J-shaped relationship with CV outcomes https://t.co/N2JEghXwSa @mvaduganathan… https://t.co/jVmFeYQuq5 https://t.co/fpqw9PGI3o
-
-
Mashup Score: 71Artificial Intelligence in Cardiovascular Clinical Trials: - 18 day(s) ago
Read the full article here
Tweet-
Read about the opportunities to apply #AI to improve CV trials throughout their life cycle, from enrollment to dissemination, in this #JACC state-of-the-art review: https://t.co/huSxVRHui2 #ArtificialIntelligence @JonWCunningham @GeoffTison @ankeetbhatt @tremartyn @SnehaShahJain… https://t.co/xhApvr4106 https://t.co/fLcByE6QqR
-
#AHA24: How does the benefit of microaxial flow pumps in cardiogenic shock vary by age? In a new analysis of the DanGer Shock trial, Dr. Jacob Møller & team at @CardResearchOuh find that these devices may not benefit older patients (>77 y/o) https://t.co/Okdi6anqPw #JACC #cvGeri… https://t.co/r00ZN3UkgL https://t.co/UV7m64rK2U